rs369483452

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_000719.7(CACNA1C):​c.76G>A​(p.Ala26Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000372 in 1,585,740 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A26V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000036 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

3
9
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 6.27

Publications

1 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.22188678).
BP6
Variant 12-2115250-G-A is Benign according to our data. Variant chr12-2115250-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 190707.
BS2
High AC in GnomAd4 at 8 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.166G>A p.Ala56Thr missense_variant Exon 2 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.166G>A p.Ala56Thr missense_variant Exon 2 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.166G>A p.Ala56Thr missense_variant Exon 2 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.166G>A p.Ala56Thr missense_variant Exon 2 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.166G>A p.Ala56Thr missense_variant Exon 2 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.166G>A p.Ala56Thr missense_variant Exon 2 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.76G>A p.Ala26Thr missense_variant Exon 2 of 46 ENSP00000507309.1 Q13936-19
CACNA1CENST00000682152.1 linkc.25G>A p.Ala9Thr missense_variant Exon 1 of 6 ENSP00000506759.1 A0A804HHT8
CACNA1CENST00000480911.6 linkn.76G>A non_coding_transcript_exon_variant Exon 2 of 27 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152202
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000560
AC:
12
AN:
214382
AF XY:
0.0000344
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000365
Gnomad NFE exome
AF:
0.0000318
Gnomad OTH exome
AF:
0.000373
GnomAD4 exome
AF:
0.0000356
AC:
51
AN:
1433538
Hom.:
0
Cov.:
32
AF XY:
0.0000395
AC XY:
28
AN XY:
709574
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32730
American (AMR)
AF:
0.0000236
AC:
1
AN:
42358
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25224
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38364
South Asian (SAS)
AF:
0.0000364
AC:
3
AN:
82334
European-Finnish (FIN)
AF:
0.000255
AC:
13
AN:
50912
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5696
European-Non Finnish (NFE)
AF:
0.0000246
AC:
27
AN:
1096680
Other (OTH)
AF:
0.000101
AC:
6
AN:
59240
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152202
Hom.:
0
Cov.:
34
AF XY:
0.0000538
AC XY:
4
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41454
American (AMR)
AF:
0.00
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5202
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000491
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000245
AC:
2
ExAC
AF:
0.0000996
AC:
12
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Cardiovascular phenotype Uncertain:2
Sep 12, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.A26T variant (also known as c.76G>A), located in coding exon 2 of the CACNA1C gene, results from a G to A substitution at nucleotide position 76. The alanine at codon 26 is replaced by threonine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the supporting evidence, the association of this alteration with CACNA1C-related neurodevelopmental disorder is unknown; however, the association of this alteration with CACNA1C-related long QT syndrome is unlikely. -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Timothy syndrome Uncertain:1
Jun 21, 2019
New York Genome Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
CardioboostArm
Benign
0.00038
BayesDel_addAF
Pathogenic
0.19
D
BayesDel_noAF
Uncertain
0.030
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.013
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Pathogenic
0.98
D
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.22
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Pathogenic
0.94
D
MutationAssessor
Benign
0.69
.;.;N;.;N;N;N;N;N;N;N;N;N;N;N;N;N;.;N;N;N;.;.;.
PhyloP100
6.3
PrimateAI
Uncertain
0.70
T
PROVEAN
Uncertain
-3.3
D;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Uncertain
0.44
Sift
Uncertain
0.0030
D;T;T;T;T;T;T;T;D;D;T;D;T;T;T;D;T;T;T;D;T;D;D;D
Sift4G
Benign
0.075
T;D;D;T;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;T;D;T
Polyphen
0.90, 0.50, 0.78, 0.85, 0.96, 1.0, 0.68
.;.;P;.;P;P;P;P;P;D;P;P;P;P;P;D;P;.;P;P;.;.;.;.
Vest4
0.53, 0.48, 0.46, 0.50, 0.48, 0.44, 0.49, 0.47, 0.49, 0.48, 0.47, 0.45, 0.48, 0.49, 0.48, 0.52, 0.47, 0.49, 0.48, 0.50, 0.51, 0.48
MVP
0.90
MPC
1.4
ClinPred
0.43
T
GERP RS
5.8
PromoterAI
0.0072
Neutral
gMVP
0.54
Mutation Taster
=42/58
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs369483452; hg19: chr12-2224416; API